A detailed history of Pacer Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 11,791 shares of OGN stock, worth $177,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,791
Previous 350 3268.86%
Holding current value
$177,218
Previous $7,000 3114.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $213,374 - $263,486
11,441 Added 3268.86%
11,791 $225,000
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $837 - $1,054
48 Added 15.89%
350 $7,000
Q4 2023

Jan 16, 2024

SELL
$10.95 - $17.32 $536,298 - $848,281
-48,977 Reduced 99.39%
302 $4,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $147,584 - $211,457
8,896 Added 22.03%
49,279 $855,000
Q2 2023

Jul 12, 2023

BUY
$19.27 - $24.63 $472,558 - $604,001
24,523 Added 154.62%
40,383 $840,000
Q1 2023

May 02, 2023

BUY
$21.42 - $32.08 $313,010 - $468,785
14,613 Added 1171.85%
15,860 $373,000
Q4 2022

Feb 06, 2023

SELL
$23.31 - $28.61 $714,078 - $876,438
-30,634 Reduced 96.09%
1,247 $34,000
Q3 2022

Oct 18, 2022

SELL
$23.4 - $34.25 $33 Million - $48.3 Million
-1,410,577 Reduced 97.79%
31,881 $746,000
Q2 2022

Aug 12, 2022

BUY
$31.66 - $38.9 $10.7 Million - $13.1 Million
336,543 Added 30.43%
1,442,458 $48.7 Million
Q1 2022

Apr 05, 2022

BUY
$30.45 - $39.36 $18.5 Million - $24 Million
609,062 Added 122.58%
1,105,915 $38.6 Million
Q4 2021

Feb 03, 2022

BUY
$28.67 - $37.13 $5.69 Million - $7.37 Million
198,413 Added 66.48%
496,853 $15.1 Million
Q3 2021

Oct 15, 2021

BUY
$28.63 - $35.64 $7.58 Million - $9.43 Million
264,653 Added 783.3%
298,440 $9.79 Million
Q2 2021

Jul 21, 2021

BUY
$28.45 - $38.0 $961,240 - $1.28 Million
33,787 New
33,787 $1.02 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.